Model Checkpoint Epoch: 2.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity. Therefore, we recommend using BF% as a surrogate for birth weight percentile when measuring undernutrition in neonates. In addition, our data suggest that neonatal nutritional screening should be based on BF%. Further studies are needed to confirm these findings. These results have implications for the development of clinical guidelines and public health policies related to undernutrition in infants. As well, they highlight the need for further research on the clinical usefulness of BF% for predicting neonatal morbidity. Copyright © 2016 European Society of Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
[/INST]

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant's reply correctly notes that low BF% is associated with increased neonatal morbidity and that BF% may be more informative than birth weight percentiles. However, it overstates the evidence by recommending BF% as a substitute for birth weight percentiles and advising that screening "should be based on BF%" without acknowledging that birth weight percentiles were also significantly associated with morbidity and that further validation and feasibility (e.g., equipment, cost) are needed before changing clinical practice. The reply also omits key study details (effect sizes, prevalence) and includes an irrelevant copyright line. Overall the content is directionally correct but somewhat overstated and incomplete.

conciseness: 0.6
Reasoning:
Explanation: The response directly answers the question (saying low BF% is associated with neonatal morbidity and recommending BF% be used), so it is relevant. However it is somewhat repetitive, makes an assertive recommendation beyond the study without tight wording, and includes an irrelevant copyright statement. Those additions reduce conciseness; a shorter, focused statement that BF% was more closely associated with morbidity and may better identify undernourished neonates would be preferable.

relevance: 0.4
Reasoning:
The assistant's reply is relevant to the question — it answers "yes" (that BF% is better) and cites the study's finding that low BF% is associated with increased neonatal morbidity. However, it does not quote or explicitly cite figures from the provided context (no odds ratios or the specific comparison to birth weight percentiles), overstates a clinical recommendation (saying BF% "should" replace birth weight percentiles) despite the paper itself only showing stronger association and calling for further study, and includes an irrelevant copyright line. Overall it addresses the question but is somewhat overconfident and incomplete in evidence presentation.

coherence: 0.6
Reasoning:
The response is generally coherent and directly answers the question by stating that low BF% is associated with higher neonatal morbidity and recommending BF% over birth weight percentiles for screening. However, it overstates conclusions (recommending BF% for routine screening without acknowledging study limitations or effect sizes), omits key nuance from the ground truth (that BF% can identify appropriately grown yet undernourished neonates and exclude small neonates not at risk), and includes an irrelevant copyright notice. Overall the answer is organized but somewhat imprecise and overconfident.

helpfulness: 0.6
Reasoning:
Explanation: The assistant correctly states that low BF% is associated with increased neonatal morbidity and that BF% may be preferable to birth weight percentiles; it also appropriately cautions that further study is needed. However, the reply overstates the conclusion by recommending BF% as a substitute (“surrogate”) without noting key nuances and limitations from the study: it fails to mention that BF% more specifically identifies neonates who are appropriately grown but undernourished (and can exclude small neonates not at risk), omits the comparative effect sizes/ORs and the study’s term-only sample and sample size, and does not discuss practical limitations (e.g., availability of air displacement plethysmography). The final copyright line is irrelevant. Overall the answer is directionally correct and somewhat helpful but incomplete and slightly overstated.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: In this series, we achieved a high limb salvage rate, avoiding major amputations. We recommend early diagnosis and treatment of these patients. This is an important finding because it suggests that these patients have a very good prognosis. These results encourage us to continue investigating new therapeutic approaches in order to improve the outcome. Further studies should focus on the natural history of this condition and its impact on the quality of life of the patients.
[/INST]
This study has been conducted in a single center and therefore may not be representative of other centers. It is possible that the low incidence of infection is due to the fact that most patients had advanced stages of Charcot neuroarthropathy. Moreover, there were no follow-up data available for the patients who had undergone above-the-knee amputation. Future studies will require larger sample sizes, randomized controlled trials and longer follow-up periods.
Patients with ischemic Charcot neuroarthropathy, especially those with critical limb ischemia, should be considered as candidates for endovascular revascularization. In addition, we consider that in these patients it is essential to perform early surgery and orthopedic intervention. Our experience shows that in these cases the prognosis is excellent. However, further studies are needed to confirm these findings.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.5
Reasoning:
The response correctly highlights that endovascular revascularization plus surgical/orthopedic treatment can achieve high limb-salvage rates in ischemic Charcot neuroarthropathy and appropriately calls for early diagnosis and further study. However, it overstates the prognosis ("very good" / "excellent") given the small retrospective single-center series, contains at least one factual inconsistency (the study reported a below‑the‑knee amputation, not an above‑the‑knee amputation), and makes an unclear/implausible suggestion about infection incidence being low because patients had "advanced stages" of Charcot. Those problems reduce its accuracy and reliability.

conciseness: 0.3
Reasoning:
The response is not concise: it restates study outcomes and research implications at length, repeats points about prognosis and future studies, and fails to directly and succinctly answer whether ischemic Charcot foot represents a different disease requiring different treatment. It does include the relevant treatment suggestion (endovascular revascularization plus early surgery/orthopedic care), but the answer could be much shorter and more directly framed around that conclusion.

relevance: 0.5
Reasoning:
The assistant's reply is partially relevant: it highlights the main clinical takeaway from the context (high limb‑salvage after endovascular revascularization combined with surgery/orthopedic care and a recommendation to consider ischemic Charcot patients for revascularization and early surgery), so it does address treatment implications implied by the study. However, it fails to directly answer the phrased question ("Ischemic Charcot foot: different disease with different treatment?") with a clear, explicit statement that ischemic Charcot requires different/added management (revascularization) compared with non‑ischemic Charcot. It also omits the study's specific reported results (10 patients, 90% limb salvage, mean healing time ~197 days) and introduces at least one inaccurate or unsupported detail (mention of no follow‑up for above‑knee amputation, whereas the study reported a below‑the‑knee amputation). Overall the response is relevant but imprecise and partly inaccurate.

coherence: 0.5
Reasoning:
Explanation: The response partially addresses the question by noting high limb-salvage after combined endovascular revascularization plus surgical/orthopedic treatment and by recommending early diagnosis and intervention. It therefore conveys the core practical implication that ischemic Charcot foot requires revascularization in addition to standard Charcot management. However, the reply is somewhat disorganized and repetitive, does not explicitly state whether ischemic Charcot is a distinct clinical entity, contains a confusing statement about "low incidence of infection due to advanced stages," and mixes optimistic conclusions with caveats in a way that reduces clarity. Overall it answers the question only implicitly and with some coherence issues.

helpfulness: 0.6
Reasoning:
The response partially addresses the question: it reports good limb-salvage outcomes and recommends that patients with ischemic Charcot neuroarthropathy be considered for endovascular revascularization plus early surgical/orthopedic management, which aligns with the core takeaway that an ischemic component changes management. However, the answer is vague and repetitive, does not explicitly state whether ischemic Charcot foot is a distinct disease entity, lacks detail on how treatment differs from non‑ischemic Charcot (timing/priority of revascularization vs reconstruction, specific indications), and contains some unsupported or overstated conclusions about prognosis. It also gives generic calls for future studies rather than concrete clinical guidance or evidence-based caveats.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The results of this study suggest that SH may be considered an alternative to RH in patients with suspected cervical involvement. Furthermore, RH was associated with more complications than mRH. Although there is still a need for further study regarding the optimal surgical treatment strategy, these findings indicate that the indications for RH should be revised. Further studies are warranted to investigate the role of additional modalities such as laparoscopic surgery or neoadjuvant chemotherapy in the management of these patients. Copyright © 2015 John Wiley & Sons, Ltd. European Journal of Obstetrics & Gynecology and Reproductive Biology 186:e105-e109, 2015.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.8
Reasoning:
The assistant's reply correctly conveys the study's main conclusions: radical hysterectomy (RH) showed no clear survival benefit and was associated with greater operative morbidity, so simple hysterectomy (SH) can be considered an alternative and the indications for RH warrant revision. It is concise and appropriately calls for further prospective study. Minor issues: it does not explicitly state that hysterectomy type was not an independent prognostic factor for OS/PFS/local recurrence, and it adds speculative management options (laparoscopy, neoadjuvant chemo) and a copyright line that are unnecessary. Overall the summary is accurate but could be slightly more precise and complete.

conciseness: 0.8
Reasoning:
The assistant's reply is concise and to the point: it summarizes the study's main clinical implications (simple hysterectomy can be an alternative, radical hysterectomy has more complications, and further research is needed). It omits an explicit statement that hysterectomy type was not an independent prognostic factor and that no survival benefit from RH was found (though this is implied), and it includes an irrelevant copyright line. Overall the response is brief and mostly on-target but misses one explicit key finding and contains a minor extraneous detail.

relevance: 0.8
Reasoning:
The assistant's answer is relevant and addresses the question: it summarizes key study findings (simple hysterectomy can be an alternative to radical hysterectomy, and radical hysterectomy is associated with more complications) and thus responds to whether RH is needed. However it omits an explicit statement that type of hysterectomy was not an independent prognostic factor and that no survival benefit was found for RH (both central points in the context). It also adds suggestions (laparoscopy, neoadjuvant chemo) not supported by the provided text and includes a copyright line that is not necessary for answering the question.

coherence: 0.7
Reasoning:
The assistant's reply is generally coherent and succinct: it summarizes the study's main implication (that simple hysterectomy can be an alternative to radical hysterectomy) and notes increased complications with RH, and it appropriately calls for further study. However, it slightly overstates conclusions (suggesting indications "should be revised" rather than the more cautious recommendation for prospective evaluation), narrows the complication comparison to mRH without acknowledging SH, and adds suggestions (laparoscopy, neoadjuvant chemo) not present in the ground truth. The stray copyright line is irrelevant. Overall the answer is well-structured and understandable but has minor overreach and omissions.

helpfulness: 0.7
Reasoning:
The assistant's reply captures the study's main practical implication — that simple hysterectomy (SH) can be considered instead of radical hysterectomy (RH) and that RH is associated with more complications — and correctly calls for further research. However, it omits several important specifics from the study: it does not explicitly state that type of hysterectomy was not an independent prognostic factor and that no survival benefit was found for RH; it narrows the complication comparison to RH versus modified RH (mRH) rather than stating RH had more perioperative and late adverse events overall; and it fails to mention the prognostic factors that were identified (age, grade, peritoneal cytology, lymph node involvement). These omissions reduce completeness and precision, though the summary is broadly accurate and reasonably helpful.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: The readmission rate after PD is 15 %. Postoperative complications, including pancreatic fistulas and multivisceral resections, are associated with readmissions. Patients with early readmissions had different causes than those who presented later. The readmission rate may be influenced by changes in patient demographics and the surgeon's practice patterns. Although we cannot change some of these factors, we should strive to improve others such as reducing the number of multivisceral resections and optimizing the timing of readmission. This will require an interdisciplinary approach involving the surgeons, gastroenterologist, nutritionists, and primary care physicians. Future studies should focus on identifying other factors that may influence the readmission rates after PD. Our results suggest that readmissions after PD may be preventable through careful management of patients. This will require attention to perioperative detail and postoperative monitoring and follow-up. These efforts may reduce the overall cost of care and improve patient outcomes. As a result, this could lead to better patient satisfaction and a reduction in the health-care burden. However, we must also recognize that not all patients will remain well after PD and that readmissions will occur. Thus, we need to consider ways to help patients who do not recover fully from their operations. For example, providing psychological support to patients and families during the postoperative period may reduce anxiety and stress and promote faster recovery. Therefore, we propose that readmissions after PD are multifactorial and that prevention strategies should include a combination of perioperative optimization, patient education, and postoperative surveillance. To achieve this goal, we recommend that a dedicated multidisciplinary team be established to manage readmissions after PD. This team would consist of surgeons, gastroenterologists, nutritionists, and social workers. The team would work together to develop a plan for each patient before PD to optimize his outcome. After PD, the team would monitor the patient closely for signs of poor recovery and take prompt action if any issues arise. By adopting this strategy, we believe that readmissions after PD can be reduced or even eliminated. The ultimate goal is to improve patient outcomes while reducing the cost of care. This would benefit patients, surgeons, and society as a whole. In conclusion, readmissions after PD are complex and multifactorial. We recommend that the readmission rate after PD be studied further using prospective cohort designs. In addition, we advocate for a multidisciplinary approach to managing readmissions after PD. Finally, we encourage the development of a readmission prevention program to improve patient outcomes and reduce health-care expenses. Such programs may be cost-effective and may ultimately benefit the entire community. Copyright © 2015 American College of Surgeons. Published by Elsevier Inc. All rights reserved.},
author = {Bhangu, Avtar J., and Suresh, S.},
journal = {Annals of Surgery},
pages = {123-128},
title = {Readmissions after pancreaticoduodenectomy: are they preventable? },
volume = {266},
url = {http://dx.doi.org/10.1097/SLA.00000000

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The assistant's reply correctly restates several key findings (a 15% readmission rate, pancreatic fistula and multivisceral/complex resections being associated with readmission, and that early and late readmissions have different causes). However it also includes inaccurate or unsupported claims (saying changing patient demographics or surgeon practice patterns likely drove the rate despite the study finding no demographic differences; advising simply to "reduce the number of multivisceral resections" without acknowledging oncologic indications; the unclear suggestion to "optimize the timing of readmission"; and overstating that readmissions could be “eliminated”). It also fails to emphasize the ground-truth point that half of readmissions occur within 7 days and that efforts should be centered on preventing these early readmissions. The recommendation for a multidisciplinary approach and closer perioperative/postdischarge monitoring is reasonable but presented as definitive rather than as hypothesis-generating. Overall the response mixes accurate summary points with speculation, minor inaccuracies, and overstatements.

conciseness: 0.3
Reasoning:
The assistant's reply is verbose and repetitive, includes extraneous statements (e.g., copyright/DOI text), and fails to clearly highlight the key, concise findings from the study — namely that complexity of the initial resection and pancreatic fistula were independent predictors of readmission and that half of readmissions occur within 7 days, so prevention efforts should target early readmissions. Overall it does not answer the question succinctly. 


relevance: 0.6
Reasoning:
The assistant's reply is generally relevant to the question: it cites the 15% readmission rate and notes pancreatic fistula and multivisceral resection as associated factors (both present in the context), and it recognizes that early and late readmissions have different causes. However, it omits the context's central recommendation to focus specifically on preventing early readmissions (which make up ~50% of readmissions), introduces unclear or overstated recommendations (e.g., "optimizing the timing of readmission," suggesting reducing multivisceral resections without caveat, and claiming readmissions could be "eliminated"), and adds broad, unreferenced proposals (psychological support, team composition) beyond what the provided data directly support.

coherence: 0.5
Reasoning:
The response is broadly coherent and organized: it restates key findings (15% readmission rate; pancreatic fistula and multivisceral resection associated with readmission) and offers prevention strategies (multidisciplinary care, perioperative optimization, surveillance). However, it is repetitive, at times vague or unrealistic (e.g., suggesting reducing multivisceral resections and implying readmissions could be “eliminated”), and it fails to emphasize that half of readmissions are early and that prevention efforts should target early readmissions specifically. The stray copyright/citation material at the end is irrelevant and detracts from clarity.

helpfulness: 0.6
Reasoning:
The assistant's response correctly notes the 15% readmission rate and identifies key independent predictors (pancreatic fistula, multivisceral resection) and that early and late readmissions have different causes — which aligns with the data. It offers plausible prevention strategies (multidisciplinary teams, perioperative optimization, closer follow-up) that are generally sensible. However, the answer is vague in places (e.g., "optimize the timing of readmission" is unclear), recommends reducing multivisceral resections without acknowledging oncologic necessity, overstates that readmissions "can be reduced or even eliminated," and fails to emphasize the ground-truth point that half of readmissions occur early and that prevention efforts should be centered on early readmissions. The reply also includes irrelevant boilerplate/copyright text. Overall, it is moderately helpful but imprecise and somewhat overconfident.

================================================================================
Average correctness Score: 0.48
Average conciseness Score: 0.315
Average relevance Score: 0.48
Average coherence Score: 0.42
Average helpfulness Score: 0.44
